Centre for Applied Pharmacokinetic Research (CAPKR), The University of Manchester, Manchester, UK.
Roche Pharma and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
AAPS J. 2020 Feb 3;22(2):41. doi: 10.1208/s12248-020-0418-7.
In physiologically based pharmacokinetic (PBPK) modelling, the large number of input parameters, limited amount of available data and the structural model complexity generally hinder simultaneous estimation of uncertain and/or unknown parameters. These parameters are generally subject to estimation. However, the approaches taken for parameter estimation vary widely. Global sensitivity analyses are proposed as a method to systematically determine the most influential parameters that can be subject to estimation. Herein, a global sensitivity analysis was conducted to identify the key drug and physiological parameters influencing drug disposition in PBPK models and to potentially reduce the PBPK model dimensionality. The impact of these parameters was evaluated on the tissue-to-unbound plasma partition coefficients (Kpus) predicted by the Rodgers and Rowland model using Latin hypercube sampling combined to partial rank correlation coefficients (PRCC). For most drug classes, PRCC showed that LogP and fraction unbound in plasma (fu) were generally the most influential parameters for Kpu predictions. For strong bases, blood:plasma partitioning was one of the most influential parameter. Uncertainty in tissue composition parameters had a large impact on Kpu and Vss predictions for all classes. Among tissue composition parameters, changes in Kpu outputs were especially attributed to changes in tissue acidic phospholipid concentrations and extracellular protein tissue:plasma ratio values. In conclusion, this work demonstrates that for parameter estimation involving PBPK models and dimensionality reduction purposes, less influential parameters might be assigned fixed values depending on the parameter space, while influential parameters could be subject to parameters estimation.
在基于生理学的药代动力学(PBPK)建模中,大量的输入参数、可用数据的有限数量和结构模型的复杂性通常会阻碍不确定和/或未知参数的同时估计。这些参数通常需要进行估计。然而,参数估计的方法差异很大。全局敏感性分析被提议作为一种系统地确定最有影响的参数的方法,这些参数可以作为估计的对象。在此,进行了全局敏感性分析,以确定影响 PBPK 模型中药物处置的关键药物和生理参数,并可能降低 PBPK 模型的维数。使用拉丁超立方抽样结合部分秩相关系数(PRCC)评估这些参数对 Rodgers 和 Rowland 模型预测的组织与未结合血浆分配系数(Kpu)的影响。对于大多数药物类别,PRCC 表明 LogP 和血浆中未结合分数(fu)通常是 Kpu 预测的最有影响的参数。对于强碱,血液:血浆分配是最有影响的参数之一。组织成分参数的不确定性对所有类别中 Kpu 和 Vss 的预测都有很大影响。在组织成分参数中,Kpu 输出的变化尤其归因于组织酸性磷脂浓度和细胞外蛋白组织:血浆比值的变化。总之,这项工作表明,对于涉及 PBPK 模型和降维目的的参数估计,不太有影响的参数可以根据参数空间赋予固定值,而有影响的参数可以作为参数估计的对象。